Press "esc" to clear
Go to Advanced Search
Showing results 2130 of 2777
  • Embargo expired:
    14-Oct-2018 6:30 PM EDT

Article ID: 701606

Pain disruption therapy treats source of chronic back pain

American Society of Anesthesiologists (ASA)

People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

8-Oct-2018 8:00 AM EDT
  • Embargo expired:
    14-Oct-2018 1:00 PM EDT

Article ID: 701602

Perioperative Surgical Home successful in improving care for both elderly and children

American Society of Anesthesiologists (ASA)

A patient-centered, team-based model of care that navigates patients through the entire surgical experience is successful in improving quality of care and outcomes in elderly patients being treated for fractures and children undergoing heart surgery, suggest two new studies being presented at the ANESTHESIOLOGY® 2018 annual meeting.

8-Oct-2018 8:00 AM EDT

Article ID: 702015

Dompé at the medical conference “The Impact of Environment and Healthy Lifestyles in Human Health” - October 13th, Washington, D.C

Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization, on the occasion of the medical conference “The impact of environment and healthy lifestyles in human health,” honoured Nathalie Dompé, CEO Dompé Holdings, with a special Award for Societal Impact in Business & Biotechnology, for her work and effort in promoting social responsibility.

13-Oct-2018 2:00 PM EDT
  • Embargo expired:
    13-Oct-2018 10:30 AM EDT

Article ID: 701683

Despite crisis, patients perceive opioids as superior and expect them for postsurgical pain

American Society of Anesthesiologists (ASA)

Even with concerns about addiction, side effects and the other risks of opioids dominating headlines, a study presented at the ANESTHESIOLOGY® 2018 annual meeting found people expect to be prescribed opioids and perceive them to be the most effective form of pain relief after surgery. Interestingly, other research presented at the meeting found opioids led to complications such as increased pain, poorer quality of life and dependence following back surgery.

8-Oct-2018 8:00 AM EDT

Article ID: 702129

University Hospitals Seidman Cancer Center Becomes First in U.S. To Use Newly FDA-Approved Drug That Makes Brain Tumors Glow Hot Pink

University Hospitals Cleveland Medical Center

Dr. Andrew Sloan of University Hospitals Seidman Cancer Center becomes first neurosurgeon to use 5-ALA in the U.S. following its FDA approval for brain cancer surgery.

12-Oct-2018 1:05 PM EDT

Article ID: 702121

Potential Therapy for Treatment-Resistant Hypothyroidism Proves Effective in Lab Study

Rush University Medical Center

A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.

12-Oct-2018 11:05 AM EDT
  • Embargo expired:
    12-Oct-2018 7:00 AM EDT

Article ID: 702008

The Addiction Institute of Mount Sinai and Center on Addiction Forge Strategic Alliance to Improve Addiction Treatment

Mount Sinai Health System

Will focus on adolescents, young adults, and their families, creating new, scalable models of care that can be disseminated nationally

10-Oct-2018 4:00 PM EDT

Article ID: 702105

A New Way to Create Molecules for Drug Development

Ohio State University

Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs.

12-Oct-2018 6:05 AM EDT

Article ID: 702066

Changes to RNA may impact growth and function of insulin-producing cells

Joslin Diabetes Center

RNA methylation might prove important in regulating many aspects of beta cell behavior, such as how the cells divide or how effectively they are stimulated by blood glucose to produce insulin

11-Oct-2018 1:05 PM EDT

Article ID: 702049

How a common drug causes liver failure

American Society for Biochemistry and Molecular Biology (ASBMB)

High doses of acetaminophen can damage the liver. Researchers have found a new mechanism by which an acetaminophen breakdown product can impair liver proteins. The compound activates a protein modification pathway called glutathionylation. The finding explains how the compound can damage even proteins it doesn't bind to directly.

11-Oct-2018 12:05 PM EDT

Showing results 2130 of 2777

Chat now!